Immunicom
company
About
Immunicom is a biotechnology company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immunicom is redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2M
Immunicom has raised a total of
$2M
in funding over 2 rounds. Their latest funding was raised on
Jun 14, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 14, 2022 | Grant | $2M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Immunicom is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
